USD 0.0
(0.0%)
Breakdown | 2021 | 2020 | 2019 |
---|---|---|---|
Operating Cash Flow | -10.54 Million | -6.89 Million | -14.7 Million |
Net Income | -24.04 Million | -23.68 Million | -32.32 Million |
Depreciation & Amortization | 6.28 Million | 7.21 Million | 11.86 Million |
Deferred income taxes | -438 Thousand | 221 Thousand | 657 Thousand |
Stock-based compensation | 722 Thousand | 904 Thousand | 1.59 Million |
Change in working capital | 5.38 Million | 6.09 Million | 2.05 Million |
Other non-cash items | 1.54 Million | 2.35 Million | 1.45 Million |
Investing Cash Flow | -10.15 Million | -5.18 Million | -9.24 Million |
Investments in PPE | -10.41 Million | -6.73 Million | -9.31 Million |
Acquisitions | - | - | - |
Investment purchases | - | - | -200 Thousand |
Sales/Maturities of investments | 260 Thousand | 970 Thousand | - |
Other Investing Activities | -8.32 Million | 578 Thousand | 273 Thousand |
Financing Cash Flow | 8.37 Million | 21.04 Million | 23.48 Million |
Debt repayment | -816 Thousand | -205 Thousand | -406 Thousand |
Dividends payments | - | - | - |
Common Stock Repurchased | - | - | - |
Common Stock Issuance | 9.01 Million | 9.06 Million | 22 Thousand |
Other Financing Activities | 180 Thousand | 12.18 Million | 23.87 Million |
Accounts receivables | 3.45 Million | - | - |
Accounts payables | - | - | - |
Inventory | 2.01 Million | -1.11 Million | 7.03 Million |
Other working capital | 3.36 Million | 7.21 Million | -4.98 Million |
Cash at beginning of period | 27.97 Million | 18.99 Million | 19.44 Million |
Cash at end of period | 15.68 Million | 27.97 Million | 18.99 Million |
Capital Expenditure | -10.41 Million | -6.73 Million | -9.31 Million |
Effect of forex changes on cash | 31 Thousand | 29 Thousand | - |
Net cash flow / Change in cash | -12.29 Million | 8.98 Million | -458 Thousand |
Free Cash Flow | -20.96 Million | -13.63 Million | -24.02 Million |
Breakdown | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 FY | 2021 Q3 | 2021 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -6487.00 | -6487.00 | -5563.50 | -24.04 Million | -5563.50 | -6157.50 |
Depreciation & Amortization | 607.00 | 607.00 | - | 6.28 Million | - | 671.00 |
Deferred income taxes | - | - | - | -438 Thousand | - | - |
Stock-based compensation | 1144.00 | 1144.00 | 361.50 | 722 Thousand | 361.50 | -244.50 |
Change in working capital | -1866.50 | -1866.50 | - | 5.38 Million | - | 727.50 |
Other non-cash items | 1045.50 | 1045.50 | 5202.00 | 1.54 Million | 5202.00 | 1496.00 |
Investing Cash Flow | -2239.50 | -2239.50 | - | -10.15 Million | - | -2327.00 |
Investments in PPE | -146.50 | -146.50 | - | -10.41 Million | - | -360.00 |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | 260 Thousand | - | - |
Other Investing Activities | -2093.00 | -2093.00 | - | - | - | -1967.00 |
Financing Cash Flow | 1950.00 | 1950.00 | - | 8.37 Million | - | 1740.50 |
Debt repayment | - | - | - | -816 Thousand | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | 9.01 Million | - | - |
Other Financing Activities | 1950.00 | 1950.00 | - | 180 Thousand | - | 1740.50 |
Accounts receivables | -146.50 | -146.50 | - | - | - | 774.50 |
Accounts payables | - | - | - | - | - | - |
Inventory | -167.50 | -167.50 | - | 2.01 Million | - | 692.00 |
Other working capital | -1552.50 | -1552.50 | - | 3.36 Million | - | -739.00 |
Cash at beginning of period | - | - | - | 27.97 Million | 19.8 Thousand | 23.89 Thousand |
Cash at end of period | -5835.00 | -5835.00 | - | 15.68 Million | 19.8 Thousand | 19.8 Thousand |
Capital Expenditure | -146.50 | -146.50 | - | -10.41 Million | - | -360.00 |
Effect of forex changes on cash | 11.50 | 11.50 | - | 31 Thousand | - | 5.00 |
Net cash flow / Change in cash | -5835.00 | -5835.00 | - | -12.29 Million | - | -4089.00 |
Free Cash Flow | -5703.50 | -5703.50 | - | -20.96 Million | - | -3867.50 |
O4B
KAYCEEI
CGBDL
ABAN
MHSDF
LUXOR-B